Jiangsu Recbio Technology Co., Ltd. Class H (HK:2179) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Jiangsu Recbio Technology Co., Ltd. plans to issue up to 143 million domestic shares, aiming to bolster its competitiveness and fund research and development initiatives. The shares will be offered to Yangtze River Pharmaceutical at RMB5.59 each, pending approval at an extraordinary general meeting. Investors are advised to remain cautious as the issuance is subject to certain conditions.
For further insights into HK:2179 stock, check out TipRanks’ Stock Analysis page.